IKT$1.540.65%-0.01
Inhibikase Therapeutics Inc (IKT)
Date: 2026-11-02 16:00O: 1.56H: 1.59L: 1.47C: 1.54Vol: 328.2k
Schlusskurs vom Vortag:
$1.55
Offen:
$1.56
24-Stunden-Volumen:
328,241
Relatives Volumen:
0.57
Marktkapitalisierung:
$214.89M
Einnahmen:
$79,600
Nettoeinkommen (Verlust:
-$48.26M
KGV:
-
EPS:
-$0.4922
Netto-Cashflow:
-$28.24M
1W Leistung:
+1.32%
1M Leistung:
-23.00%
6M Leistung:
-19.37%
1Y Leistung:
+4.76%
1-Tages-Spanne:
$1.47$1.59
1-Wochen-Bereich:
$1.47$1.70
52-Wochen-Spanne:
$1.33$2.61
Inhibikase Therapeutics Inc Aktie (IKT) Unternehmensprofil
Firmenname
Inhibikase Therapeutics IncSektor
HealthcareBranche
BiotechnologyTelefon
(302) 295-3800Adresse
1000 N. WEST STREET, SUITE 1200, WILMINGTON, USAIKT vs. VRTX, REGN, MRNA, ARGX, ONC vergleichen
| Aktien | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|
IKT Inhibikase Therapeutics Inc | $214.89M | $0 | -$60.64M | -$42.61M | -$0.4922 |
 VRTX Vertex Pharmaceuticals Inc | $140.94B | $12.59B | $4.41B | $3.80B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $99.46B | $16.90B | $4.82B | $3.83B | $41.04 |
 MRNA Moderna Inc | $88.17B | $2.23B | -$3.15B | -$1.24B | -$8.15 |
 ARGX Argen X Se Adr | $55.03B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $40.86B | $6.13B | $655.71M | $1.33B | $4.48 |
Inhibikase Therapeutics Inc Aktie (IKT) Hochstufungen & Herabstufungen
Finanzdaten der Inhibikase Therapeutics Inc-Aktie (IKT)
Inhibikase Therapeutics Inc-Aktie (IKT) Insiderhandel
- BERMAN DENNIS NJul 30 '26Director
- Transaktion
- Option Exercise
- Kosten
- $1.26
- #Aktien
- 21,854
- Wert ($)
- 27,536
- #Aktien Gesamt
- 21,854
- Sands Capital Life Sciences PuNov 21 '2510% Owner
- Transaktion
- Buy
- Kosten
- $1.45
- #Aktien
- 2,068,965
- Wert ($)
- 2,999,999
- #Aktien Gesamt
- 13,018,965
